NCT03450759 - A Single Oral Dose Study to Evaluate Four Different Formulations of AZD9977 and the Effect of Food in Healthy Male Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 28, 2018

Primary Completion Date

June 6, 2018

Study Completion Date

June 6, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

AZD9977 Oral suspension (reference)

Randomized subjects will receive single oral dose of AZD9977 oral suspension 15 mg/mL on Days 1, 3, 5 and 7 in Part A.

DRUG

AZD9977 capsule

Randomized subjects will receive single oral dose of AZD9977 capsule 65 mg on Days 1, 3, 5 and 7 in Part A.

DRUG

AZD9977 ER capsule (fastvrate)

Randomized subjects will receive single oral dose of AZD9977 ER capsule (fast rate) 65 mg on Days 1, 3, 5 and 7 in Part A.

DRUG

AZD9977 ER capsule (Int. rate)

Randomized subjects will receive single oral dose of AZD9977 ER capsule (Int rate) 65 mg on Days 1, 3, 5 and 7 in Part A.

Trial Locations (1)

Research Site, London